December 19, 2018 / 2:59 PM / a month ago

BRIEF-Intec Pharma - Plan To Initiate A PK Study Of AP-Cannabidiol (CBD) In First Half Of 2019

Dec 19 (Reuters) - Intec Pharma Ltd:

* INTEC PHARMA PUBLISHES LETTER TO SHAREHOLDERS

* INTEC PHARMA LTD - PLAN TO INITIATE A PK STUDY OF AP-CANNABIDIOL (CBD) IN FIRST HALF OF 2019.

* INTEC PHARMA LTD - WILL HAVE GREATER GRANULARITY ON COMMERCIAL SCALE MANUFACTURING STRATEGY REQUIREMENTS AND TIMELINES IN Q2 2019

* INTEC PHARMA - TOGETHER WITH NOVARTIS CO HAS AGREED TO PROCEED WITH ACCORDION PILL PROGRAM, PLANS TO ENTER CLINIC WITH A FIRST-IN-HUMAN PK STUDY IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below